Mizue Krygowski

1.3k citations
13 papers · 992 indexed · h-index 10
Topics
Renal cell carcinoma treatment (7 papers)Cancer Genomics and Diagnostics (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)

In The Last Decade

Mizue Krygowski

13 papers receiving 974 citations

Peers

Mizue Krygowski
Comparison fields: 5 of 55
  • Pulmonary and Respiratory Medicine 659
  • Molecular Biology 640
  • Oncology 360
  • Cancer Research 343
  • Genetics 96
Replace Yu-Nien Sun with:
Yu-Nien Sun United States
Heidi Steinfeldt United States
Cinta Hierro Spain
Deborah Ricci United States
Marie‐Paule Sablin France
Tania Mariani United States
Jakub Żołnierek Poland
Daygen L. Finch Canada
Yifah Yaron United States
Suparna Wedam United States
Mizue Krygowski relative to Yu-Nien Sun United States Yu-Nien Sun's profile →
Citations per field
00.5×1.5×2.1×
Yu-Nien Sun · 1×
Citations per year

Countries citing papers authored by Mizue Krygowski

Since Specialization
Citations

This map shows the geographic impact of Mizue Krygowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mizue Krygowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mizue Krygowski more than expected).

Fields of papers citing papers by Mizue Krygowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mizue Krygowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mizue Krygowski. The network helps show where Mizue Krygowski may publish in the future.

Co-authorship network of co-authors of Mizue Krygowski

This figure shows the co-authorship network connecting the top 25 collaborators of Mizue Krygowski. A scholar is included among the top collaborators of Mizue Krygowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mizue Krygowski. Mizue Krygowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 11
2 160
3 21
4 222
5 83
6 103
7 80
8 7
9 67
10 194
11 9
12 7
13 28

About Mizue Krygowski

Mizue Krygowski is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cancer Research, having authored 13 papers that have together received 992 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Cancer Genomics and Diagnostics (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (343 citations), Pulmonary and Respiratory Medicine (659 citations) and Oncology (360 citations). Mizue Krygowski has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Anna Berkenblit, Andrew Strahs, Janice P. Dutcher, Gary R. Hudes, Revathi Ananthakrishnan, Alexandra Thiele, Robert A. Figlin, Jay Feingold, Paul de Souza and David F. McDermott. Their work appears in journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026